SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-23-028897
Filing Date
2023-08-10
Accepted
2023-08-10 16:33:22
Documents
79
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q xfor-20230630.htm   iXBRL 10-Q 1341924
2 EX-10.3 ex103anr2019inducementequi.htm EX-10.3 91358
3 EX-10.4 a104amendedandrestated2017.htm EX-10.4 50227
4 EX-31.1 ex-311q22023.htm EX-31.1 9258
5 EX-31.2 ex-312q22023.htm EX-31.2 9246
6 EX-32.1 ex-321q22023.htm EX-32.1 5448
12 xfor-20230630_g1.jpg GRAPHIC 469223
  Complete submission text file 0001628280-23-028897.txt   7740328

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xfor-20230630.xsd EX-101.SCH 50519
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT xfor-20230630_cal.xml EX-101.CAL 61758
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT xfor-20230630_def.xml EX-101.DEF 206041
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xfor-20230630_lab.xml EX-101.LAB 551427
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xfor-20230630_pre.xml EX-101.PRE 367951
73 EXTRACTED XBRL INSTANCE DOCUMENT xfor-20230630_htm.xml XML 868683
Mailing Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134
Business Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134 857-529-8300
X4 Pharmaceuticals, Inc (Filer) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38295 | Film No.: 231160120
SIC: 2836 Biological Products, (No Diagnostic Substances)